Calliditas Therapeutics Ab ADR (NQ: CALT )
38.15
+15.73
(+70.14%)
Streaming Delayed Price
Updated: 10:44 AM EDT, May 28, 2024
Add to My Watchlist
Headline News about Calliditas Therapeutics Ab ADR
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|